| International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA) J Savige, D Gillis, E Benson, D Davies, V Esnault, RJ Falk, E Chris Hagen, ... American journal of clinical pathology 111 (4), 507-513, 1999 | 729 | 1999 |
| Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 492 | 2019 |
| KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron H Louis-Dit-Picard, J Barc, D Trujillano, S Miserey-Lenkei, N Bouatia-Naji, ... Nature genetics 44 (4), 456-460, 2012 | 339 | 2012 |
| A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease C Couchoud, M Labeeuw, O Moranne, V Allot, V Esnault, L Frimat, ... Nephrology Dialysis Transplantation 24 (5), 1553-1561, 2009 | 308 | 2009 |
| Alpha1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis VLM Esnault, A Testa, M Audrain, C Rogé, M Hamidou, JH Barrier, ... Kidney international 43 (6), 1329-1332, 1993 | 252 | 1993 |
| High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial F Cantarovich, B Rangoonwala, H Lorenz, M Verho, VLM Esnault American journal of kidney diseases 44 (3), 402-409, 2004 | 222 | 2004 |
| Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy B Seitz-Polski, G Dolla, C Payré, CA Girard, J Polidori, K Zorzi, ... Journal of the American Society of Nephrology 27 (5), 1517-1533, 2016 | 197 | 2016 |
| ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin DRW Jayne, VLM Esnault, CM Lockwood Journal of autoimmunity 6 (2), 207-219, 1993 | 164 | 1993 |
| Adherence to antihypertensive treatment and the blood pressure–lowering effects of renal denervation in the renal denervation for hypertension (DENERHTN) trial M Azizi, H Pereira, I Hamdidouche, P Gosse, M Monge, G Bobrie, ... Circulation 134 (12), 847-857, 2016 | 159 | 2016 |
| Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents VLM Esnault, AMR Ekhlas, C Delcroix, JM Nguyen Journal of the American Society of Nephrology 16 (2), 474-481, 2005 | 158 | 2005 |
| Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy C Dähnrich, L Komorowski, C Probst, B Seitz-Polski, V Esnault, ... Clinica Chimica Acta 421, 213-218, 2013 | 148 | 2013 |
| Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive … AK Short, VLM Esnault, CM Lockwood American journal of kidney diseases 26 (3), 439-445, 1995 | 144 | 1995 |
| Visceral fat is associated to the severity of COVID-19 G Favre, K Legueult, C Pradier, C Raffaelli, C Ichai, A Iannelli, A Redheuil, ... Metabolism 115, 154440, 2021 | 135 | 2021 |
| Activation of normal neutrophils by anti‐neutrophil cytoplasm antibodies MT Keogan, VLM Esnault, AJ Green, CM Lockwood, DL Brown Clinical & Experimental Immunology 90 (2), 228-234, 1992 | 132 | 1992 |
| Modulation of glucose metabolism by the renin-angiotensin-aldosterone system GA Favre, VLM Esnault, E Van Obberghen American Journal of Physiology-Endocrinology and Metabolism 308 (6), E435-E449, 2015 | 125 | 2015 |
| Autoantibodies to myeloperoxidase in brown Norway rats treated with mercuric chloride. VL Esnault, PW Mathieson, S Thiru, DB Oliveira, C Martin-Lockwood Laboratory Investigation; a Journal of Technical Methods and Pathology 67 (1 …, 1992 | 107 | 1992 |
| French Renal Epidemiology and Information Network (REIN) registry. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease C Couchoud, M Labeeuw, O Moranne, V Allot, V Esnault, L Frimat, ... Nephrol Dial Transplant 24 (5), 1553-61, 2009 | 105 | 2009 |
| Phospholipase A2 receptor 1 epitope spreading at baseline predicts reduced likelihood of remission of membranous nephropathy B Seitz-Polski, H Debiec, A Rousseau, K Dahan, C Zaghrini, C Payré, ... Journal of the American Society of Nephrology 29 (2), 401-408, 2018 | 102 | 2018 |
| High-dose rituximab and early remission in PLA2R1-related membranous nephropathy B Seitz-Polski, K Dahan, H Debiec, A Rousseau, M Andreani, C Zaghrini, ... Clinical Journal of the American Society of Nephrology 14 (8), 1173-1182, 2019 | 97 | 2019 |
| TREATMENT OF GRAFT-VERSUS-HOST DISEASE BY EXTRACORPOREAL PHOTOCHEMOTHERAPY: A Pilot Study: 1 DP Besnier, D Chabannes, B Mahe, JMG Mussini, TAR Baranger, ... Transplantation 64 (1), 49-54, 1997 | 94 | 1997 |
